Ratlarda Femoral Arter Kanama Modelinde Bitki Bazlı Algan Hemostatik Ajanın Etkinliğinin Araştırılması
PDF
Atıf
Paylaş
Talep
P: 88-95
Şubat 2022

Ratlarda Femoral Arter Kanama Modelinde Bitki Bazlı Algan Hemostatik Ajanın Etkinliğinin Araştırılması

Bezmialem Science 2022;10(1):88-95
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 08.11.2020
Kabul Tarihi: 16.02.2021
Yayın Tarihi: 26.01.2022
PDF
Atıf
Paylaş
Talep

ÖZET

Amaç:

Bu çalışmanın amacı, sıçanlarda femoral arter insizyon modelinde üç farklı fiziksel formda (sıvı, toz ve spança emdirilmiş) bulunan Algan Hemostatik Ajanın (AHA) etkinliğini değerlendirmektir.

Yöntemler:

Çalışmada toplam 64 adet 5-7 haftalık rat kullanıldı. Ratlar rastgele olarak her biri sekiz rattan oluşan 4 gruba (4 grup heparinize ve 4 grup nonheparinize) ayrıldı. Deneysel femoral arter insizyonu oluşturuldu. Kontrol olarak serum fizyolojik emdirilmiş spanç uygulandı. Deney gruplarına AHA sıvısı, AHA tozu ve AHA sıvısı emdirilmiş spanç formları uygulandı.

Bulgular:

Kanama bölgelerine uygulanan tüm AHA formları kontrol grubuna göre anlamlı olarak daha kısa sürede kanamayı durdurdu (p<0.05). Buna karşılık, kontrol grubunda kanama 4 dakika içinde kontrol edilemedi. En iyi sonuç AHA toz formundaydı ve heparinize olmayan grupta kanamayı birinci dakikada %87,5 ve ikinci dakikada %12,5 oranında kontrol edebildi. Heparinize grupta AHA toz formu birinci dakikada %62,5, ikinci dakikada ise %37,5 oranında kanamayı kontrol edebildi.

Sonuç:

Bu çalışma, AHA'nın kanama kontrolünde oldukça etkili ve umut verici bir hemostatik ajan olduğunu göstermektedir.

References

1
Abacıoğlu S, Aydın K, Büyükcam F, Abacıoğlu S, Aydın K, Büyükcam F, Kaya U, Işık B, Karakılıç ME. Comparison of the efficiencies of buffers containing Ankaferd and Chitosan on hemostasis in an experimental rat model with femoral artery bleeding. Turk J Hematol 2016;33:48-52.
2
Aktop S, Emekli-Alturfan E, Ozer C, Gonul O, Garip H, et al. Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. Clin Appl Thromb Hemost 2014;20:16-21.
3
Bennett BL, Littlejohn LF, Kheirabadi BS, Butler FK, Kotwal RS, Dubick MA, et al. Management of External Hemorrhage in Tactical Combat Casualty Care: Chitosan-Based Hemostatic Gauze Dressings. JSOM 2014;14:12-29.
4
Bracey A, Shander A, Aronson S, Boucher BA, Calcaterra D, Chu MWA, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg 2017;104:353-60.
5
Brunett PH, Cameron PA. Trauma in adults. 1669-1676. In: Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD, Editors. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. McGraw Hill, New York. 2010.
6
Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther 2007;24:485-92.
7
Glickman M, Gheissari A, Money S, Martin J, Ballard JL; CoSeal Multicenter Vascular Surgery Study Group. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial. Arch Surg 2002;137:326-31.
8
Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the hemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 2003;35:439-44.
9
Huri E, Akgül KT, Yücel MÖ, Astarcı HM, Üstün H, Germiuanoğlu RC. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci 2011;41:7-15.
10
Jackson MR.  New and potential uses of fibrin sealants as an adjunct to surgical hemostasis. Am J Surg 2001;182:36-9.
11
Karahaliloğlu Z, Demirbilek M, Ulusoy İ, Gümüşkaya B, Denkbaş EB. Hemostatic activities of nano/microporous bilayer dressings in a femoral artery bleeding rat model. J Appl Polym Sci 2016;133:43657.
12
Letourneau PA, McManus M, Sowards K, Wang W, Wang YW, Matijevic N, et al. Aged plasma transfusion increases mortality in a rat model of uncontrolled hemorrhage. J Trauma 2011;71:1115-9.
13
Lew WK, Weaver FA. Clinical use of topical thrombin as a surgical hemostat. Biologics 2008;2:593-9.
14
Lih E, Lee JS, Park KM, Park KD. Rapidly curable chitosan-PEG hydrogels as tissue adhesives for hemostasis and wound healing. Acta biomater 2012;8:3261-9.
15
Midi A, Kumandaş A, Ekici H, Arda S, Karahan S, Şimşek AK, et al. Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. EJMI 2018;2:129-32.
16
Midi A, Ozyurek HE, Karahan S, Ekici H, Kumandas A, Turkmen I, et al. Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. EJMI 2018;2:195-201.
17
Midi A, Ekici H, Kumandas A, Durmus O, Bodıc B, Tıryakı M, et al.  Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J 2019;32:27-32.
18
Midi A, Kumandas A, Ekici H, Bayraktar F, Karapirli K, Karahan S, et al. Investigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Rats. EJMO 2019;3:37-42.
19
Ohta S, Nishiyama T, Sakoda M, Machioka K. Development of carboxymethyl cellulose nonwoven sheet as a novel hemostatic agent. J Biosci Bioeng 2015;119:718-23.
20
Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233:88-96.
21
Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J 2011;94:1-20.
22
Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008;48:1502-16.
23
Spotnitz WD, Burks S. State-of-the-art review: hemostats, sealants, and adhesives II. Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thomb Hemost 2010;16:497-514.
24
Spotnitz WD.  Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg 2012;78:1305-21.
25
Srivastava CM, Purwar R. Chitosan‐finished Antheraea mylitta silk fibroin nonwoven composite films for wound dressing. J Appl Polym Sci 2017;134:44341.
26
Su Z, Izumi T, Thames EH, Lawson JH, Ortel TL. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin. J Lab Clin Med 2002;139:349-56.
27
Ward KR, Tiba MH, Holbert WH, Blocher CR, Draucker GT, Proffitt EK, et al. Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 2007;63:276-83.
28
Xu HX, Yan YU, Wang XY, Ma K, Chao Y, Sun PJ, et al. Hemostatic effect of a medical polysaccharide hemostatic healing sponge on hemostasis of bleeding from femoral artery in pigs. Med J Chin PLA 2015;40:245-7.
29
Yan D, Hu S, Zhou Z, Zeenat S, Cheng F, Li Y, et al. Different chemical groups modification on the surface of chitosan nonwoven dressing and the hemostatic properties. Int J Biol Macromol 2018;107:463-9.
2024 ©️ Galenos Publishing House